-

IFF Announces Expansion of Cedar Rapids, Iowa Ingredients Facility

At our new, state-of-the-art facility, IFF will produce high-quality fruit-based ingredients for snack manufacturers, aiming to provide a promising return on investment.

NEW YORK--(BUSINESS WIRE)--IFF (NYSE: IFF) today unveiled plans to expand its Cedar Rapids, Iowa facility to capture a larger share of the booming healthy snacks market both in the U.S. and globally. The 47,000-square-foot expansion represents a nearly $70 million investment. When fully operational in the latter half of 2026, the expansion is projected to create up to 40 new jobs.

“Our Cedar Rapids plant will be equipped with cutting-edge technologies, allowing us to provide U.S.-made TAURA by IFF fruit ingredients that can be easily integrated into food manufacturing processes,” said Andy Muller, president of Food Ingredients. “Additionally, sustainability is at the forefront of this project, aligning with our commitment to Do More Good.”

Leveraging more than three decades of proprietary technology, this expansion will give IFF a significant competitive edge in the healthy snacks sector. The facility will feature high automation, advanced packaging and ergonomic designs. Its proximity to U.S. customers will enhance supply chain efficiencies. Moreover, the new facility will prioritize sustainability, incorporating efficient heat recovery systems, minimizing energy and water consumption, and utilizing reusable methods for raw material handling.

“The expansion project at Cedar Rapids represents the first US IFF facility to focus on TAURA by IFF ingredients,” said Muller. “TAURA’s clean-label fruit and vegetable pieces and pastes provide manufacturers with versatile formats for creating differentiated products with natural appeal.”

TAURA ingredients empower manufacturers to infuse long shelf-life food products, such as grab-and-go snacks, enhanced chocolates, cereals, and bakery items, with the multi-sensory appeal of real fruit. Utilizing innovative technology, these ingredients are crafted by removing moisture while preserving the original fruit's integrity. IFF currently produces TAURA ingredients in Belgium and New Zealand.

This expansion will complement the existing Cedar Rapids plant—which currently produces enzymes used in food, household and personal care, and animal nutrition products, as well as biofuels production—and has already seen substantial enhancements in recent years. Altogether, IFF employs more than 200 workers in Cedar Rapids.

Cautionary Statement under the Private Securities Litigation Reform Act of 1995

This press release contains “forward-looking statements” within the meaning of the federal securities laws, including Section 27A of the Securities Act, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Forward-looking statements often address expected future business and financial performance and financial condition, and often contain words such as “”plan”, “expect,” “anticipate,” “intend,” “believe,” “seek,” “see,” “will,” “would,” “target,” similar expressions, and variations or negatives of these words. Forward-looking statements by their nature address matters that are, to different degrees, uncertain, such as statements about the timing or nature of the proposed expansion. The forward-looking statements included in this release are made only as of the date hereof, and we undertake no obligation to update the forward-looking statement to reflect subsequent events or circumstances.

Welcome to IFF

At IFF (NYSE: IFF), we make joy through science, creativity and heart. As the global leader in flavors, fragrances, food ingredients, health and biosciences, we deliver groundbreaking, sustainable innovations that elevate everyday products—advancing wellness, delighting the senses and enhancing the human experience. Learn more at iff.com, LinkedIn, Instagram and Facebook.

© 2025 by International Flavors & Fragrances Inc. IFF is a Registered Trademark. All Rights Reserved.

Contacts

Media Relations:
Paulina Heinkel
332.877.5339
Media.request@iff.com

Investor Relations:
Michael Bender
212.708.7263
Investor.Relations@iff.com

IFF

NYSE:IFF

Release Versions

Contacts

Media Relations:
Paulina Heinkel
332.877.5339
Media.request@iff.com

Investor Relations:
Michael Bender
212.708.7263
Investor.Relations@iff.com

More News From IFF

IFF and Kemira Form Joint Venture To Produce Sustainable Biobased Materials at Scale

NEW YORK--(BUSINESS WIRE)--IFF (NYSE:IFF) and Kemira announced the formation of Alpha Bio, a joint venture aimed at commercial-scale production of renewable biobased materials. With an investment of approximately €130 million, the Alpha Bio facility will start production in late 2027, converting up to 44,000 MT of plant sugars to bioproducts, including high-performance biopolymers for use in various applications, such as home and personal care and industrial solutions. Alpha Bio’s production wi...

IFF Pharma Solutions Brings Next-Gen Excipient Innovations to CPHI Japan 2025

TOKYO--(BUSINESS WIRE)--IFF (NYSE:IFF) Pharma Solutions will showcase its cutting-edge excipient technologies at CPHI Japan 2025. The IFF Pharma Solutions team will highlight its innovations in oral disintegrating tablets (ODTs), controlled-release formulations, and novel complex formulations at booth 5K-21, Tokyo Big Sight East Halls 4-6, April 9-11. “IFF Pharma Solutions is committed to redefining drug delivery through material science innovation,” said Frank Zhao, commercial leader, IFF Phar...

IFF Declares Dividend for First Quarter 2025

NEW YORK--(BUSINESS WIRE)--IFF (NYSE: IFF) announced that its Board of Directors has declared a regular quarterly cash dividend of $0.40 per share of its common stock, payable on April 11, 2025 to shareholders of record as of March 21, 2025. Welcome to IFF At IFF (NYSE: IFF), we make joy through science, creativity and heart. As the global leader in flavors, fragrances, food ingredients, health and biosciences, we deliver groundbreaking, sustainable innovations that elevate everyday products—ad...
Back to Newsroom
  1. There was an issue with the authorization server. Please contact support if the issue persists.